{
  "ptid_time": "041_S_4720_2014-05-12",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4720/2014-05-12/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 6,383 mm³, 15.6% below the reference mean. With a Z-score of -1.52 (6.5th percentile), this represents moderate atrophy; whole brain volume measures 1,107,880 mm³, 2.6% above the reference mean. With a Z-score of 0.34 (63.4th percentile), this represents normal volume ; entorhinal cortex volume measures 4,467 mm³, 8.9% above the reference mean. With a Z-score of 0.61 (72.8th percentile), this represents normal volume ; fusiform gyrus volume measures 22,088 mm³, 17.2% above the reference mean. With a Z-score of 1.47 (92.9th percentile), this represents mild enlargement; middle temporal gyrus volume measures 21,232 mm³, 0.5% below the reference mean. With a Z-score of -0.05 (48.2th percentile), this represents normal volume . ",
  "text_data": "Age is 79.4 years. Gender is Male. Education: 16 years. MMSE: 27.0. MoCA: 20.0. Logical Memory: 0.0. APOEε4 alleles: 2.0. Biomarker levels: Amyloid beta: 535.60 pg/mL (mild reduced); Total tau: 359.60 pg/mL (moderate elevated); Phosphorylated tau: 35.48 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate hippocampal atrophy (Z-score -1.52, 6.5th percentile) alongside normal whole brain and entorhinal cortex volumes. Cognitive testing reveals borderline MoCA (20/30) with preserved MMSE (27/30), suggesting mild cognitive deficits. Biomarkers (Aβ reduction, elevated T-tau/P-tau) support Alzheimer’s pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s disease)  \n**Confidence:** **High**  \n\n*(Rationale: Hippocampal atrophy + biomarker profile strongly suggest early AD, but preserved MMSE and lack of functional decline preclude dementia diagnosis.)*",
  "timestamp": "2025-07-26T07:20:03.247854"
}